` AXSM (Axsome Therapeutics Inc) vs S&P 500 Comparison - Alpha Spread

AXSM
vs
S&P 500

Over the past 12 months, AXSM has significantly outperformed S&P 500, delivering a return of 44% compared to the S&P 500's 6% growth.

Stocks Performance
AXSM vs S&P 500

Loading

Performance Gap
AXSM vs S&P 500

Sign Up to see
Performance Gap
Sign In
Sign Up

Performance By Year
AXSM vs S&P 500

Loading
AXSM
S&P 500
Add Stock

Competitors Performance
Axsome Therapeutics Inc vs Peers

S&P 500
AXSM
LLY
JNJ
NOVO B
ROG
Add Stock

Axsome Therapeutics Inc
Glance View

Market Cap
4.8B USD
Industry
Pharmaceuticals

Axsome Therapeutics Inc. emerged as a dynamic player in the biopharmaceutical arena, driven by a resolute commitment to alleviate the burdensome effects of central nervous system (CNS) disorders. Founded with a vision to fill critical treatment gaps in neurologically influenced conditions, Axsome leverages innovative drug discovery and development to address medical needs that have long been underserved. The company focuses intently on conditions such as depression, migraine, narcolepsy, and Alzheimer's disease-related agitation, channeling resources into a streamlined pipeline that seeks to fast-track the development and commercialization of life-changing therapies. Operating at the intersection of cutting-edge science and patient-centric healthcare, Axsome generates revenue through the successful approval and marketing of its proprietary pharmaceutical products. The company's business model hinges on advancing its clinical candidates through rigorous trials, eventually gaining the necessary regulatory endorsements to bring them to market. By holding the intellectual property rights for these novel drugs, Axsome enjoys the advantages of exclusivity in the marketplace, which allows it to negotiate favorable pricing and reimbursement terms. This strategic approach not only positions Axsome as a potentially transformative force within the pharmaceutical industry but also underlines its commitment to producing viable, accessible treatments for those grappling with debilitating CNS disorders.

AXSM Intrinsic Value
HIDDEN
Show
Back to Top